Inicio / Metabolismo Óseo y Mineral (página 2)

Metabolismo Óseo y Mineral

The Orthopaedic Implications of Diphosphonate Therapy

Última actualización 24/06/10J Am Acad Orthop Surg, Vol 18, No 6, June 2010 Michael J. Weaver, MD, Micah A. Miller, BS and Mark S. Vrahas, MD Diphosphonates are among the many commonly prescribed drugs for osteoporosis management. These synthetic analogues of physiologically occurring inorganic pyrophosphate bind to the hydroxyapatite crystals …

Leer más »

Effect of Alendronate on Pseudomembrane Cytokine Expression in Patients with Aseptic Osteolysis

Última actualización 16/12/09Holt G, Reilly J, Meek RM; Journal of Arthroplasty (Dec 2009) AIM: To determine whether alendronate alters the pseudomembrane inflammatory cytokine profile in patients with established aseptic osteolysis. METHODS: A prospective, double-blind, randomized, controlled trial was conducted. Ten individuals listed for revision surgery for aseptic failure of a …

Leer más »

Bazedoxifene, a selective estrogen receptor modulator: effects on the endometrium, ovaries, and breast from a randomized controlled trial in osteoporotic postmenopausal women.

Última actualización 11/12/09Archer DF, Pinkerton JV, Utian WH, Menegoci JC, de Villiers TJ, Yuen CK, Levine AB, Chines AA, Constantine GD. Menopause. 2009 Nov-Dec;16(6):1079-82. OBJECTIVE: The aim of this study was to evaluate the endometrial, ovarian, and breast safety of bazedoxifene used as a treatment for postmenopausal osteoporosis. METHODS: Healthy …

Leer más »

Recognition and management of vitamin D deficiency.

Última actualización 2/12/09Am Fam Physician. 2009 Oct 15;80(8):841-6. Bordelon P, Ghetu MV, Langan RC. Vitamin D deficiency affects persons of all ages. Common manifestations of vitamin D deficiency are symmetric low back pain, proximal muscle weakness, muscle aches, and throbbing bone pain elicited with pressure over the sternum or tibia. …

Leer más »

Diagnosis and treatment of osteoporosis

Última actualización 27/02/09American Family Physician 79 (3), 193-200 (Feb 2009) Sweet MG, Sweet JM, Jeremiah MP, Galazka SS; Osteoporosis affects approximately 8 million women and 2 million men in the United States. The associated fractures are a common and preventable cause of morbidity and mortality in up to 50 percent …

Leer más »

Giant osteoclast formation and long-term oral bisphosphonate therapy

Última actualización 28/01/09N Engl J Med. 2009 Jan 1;360(1):53-62. Weinstein RS, Roberson PK, Manolagas SC BACKGROUND: Bisphosphonates decrease bone resorption and are commonly used to treat or prevent osteoporosis. However, the effect of bisphosphonates on their target cells remains enigmatic, since in patients benefiting from therapy, little change, if any, …

Leer más »

Oral bisphosphonate use and the prevalence of osteonecrosis of the jaw

Última actualización 15/01/09J Am Dent Assoc, 2009. Vol 140, No 1, 61-66. Parish P. Sedghizadeh, DDS, MS, Kyle Stanley, BS, Matthew Caligiuri, BA, Shawn Hofkes, BS, Brad Lowry, BS and Charles F. Shuler, DMD, PhD Background. Initial reports of osteonecrosis of the jaw (ONJ) secondary to bisphosphonate (BP) therapy indicated …

Leer más »

Prevalence of and Traits Associated With Low BMD Among Female Adolescent Runners

Última actualización 26/12/08Med Sci Sports Exerc 40(12) 2008 Michelle T. Barrack; Mitchell J. Rauh; Jeanne F. Nichols Abstract Purpose: Identify the prevalence of and traits that may increase the risk of low bone mineral density (BMD) among 93 female adolescent competitive endurance runners. Methods: Participants were 93 high school runners, …

Leer más »

Osteoporosis and osteoporotic fracture occurrence and prevention in the elderly: a geriatric perspective

Última actualización 17/12/08Best Pract Res Clin Endocrinol Metab. 2008 Oct;22(5):765-85. Boonen S, Dejaeger E, Vanderschueren D, Venken K, Bogaerts A, Verschueren S, Milisen K. Age is a major determinant of osteoporosis, but the elderly are rarely assessed and often remain untreated for this condition. Falls, co-morbidities and co-medications compound the …

Leer más »

Lithium’s effect on bone mineral density

Última actualización 9/12/08Bone. 2008 Oct 18. [Epub ahead of print] Zamani A, Omrani GR, Nasab MM. Lithium salts are widely used in treating psychiatric patients. Lithium may be associated with hyperparathyroidism, a risk factor for osteoporosis. However, the data on the effect of lithium on bone mass are conflicting. We …

Leer más »